Osvyrti Injection
Product Images NDC 69448-021

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Osvyrti (NDC 69448-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Biopharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 01)

An instructional diagram showing a subcutaneous injection syringe labeled "Before use" and "After use." The syringe parts are labeled, including plunger head, plunger rod, needle guard activation clip, finger grip, label and expiration date, safety guard, syringe barrel, inspection window, safety guard spring, and gray needle cap. The "After use" image shows the used plunger head, extended safety guard spring, and the gray needle cap removed.*

FDA Label Image

Image (Image 02)

An instructional illustration showing a hand removing the cap from the needle of a prefilled syringe. The syringe is held upright with the needle pointing up and an arrow indicates the cap being pulled off. This image is relevant for subcutaneous injection preparation of OSVYRTI (denosumab-desu) 60 mg/mL.*

FDA Label Image

Image (Image 03)

An anatomical illustration showing recommended subcutaneous injection sites on the human body for OSVYRTI (denosumab-desu) injection. Highlighted areas include the upper arm, abdomen, and upper thigh.*

FDA Label Image

Image (Image 04)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin, while another hand stretches the skin taut. This diagram demonstrates the proper technique for administering an injection, relevant for the OSVYRTI (denosumab-desu) 60 mg/mL subcutaneous injection.*

FDA Label Image

Image (Image 05)

An instructional illustration showing two hands administering a subcutaneous injection using a syringe device. The top hand holds the syringe upright while the bottom hand pinches the skin, preparing for the injection. An arrow above the syringe indicates an upward motion.*

FDA Label Image

Image (Image 06)

An instructional illustration showing a hand holding a syringe for subcutaneous injection. The image depicts the proper injection technique with an arrow indicating upward motion as the needle is inserted into the skin.*

FDA Label Image

Figure 1 (Image 07)

A line graph comparing patient hip fracture incidence (%) over a 36-month study period between two groups: placebo (N=3906) represented by a dashed line, and denosumab (N=3902) represented by a solid line. The horizontal axis shows study months from 0 to 36, and the vertical axis shows patient hip fracture incidence from 0% to 10%. The graph illustrates lower fracture incidence in the denosumab group compared to placebo over time.*

FDA Label Image

Principal Display Panel (60 mg/mL Syringe Carton)

Label for OSVYRTI (denosumab-desu) injection, 60 mg/mL, a single-dose prefilled syringe for subcutaneous use. The label includes NDC 69448-021-63, lot and expiration placeholders, a barcode, and states manufacturing by Accord BioPharma Inc. U.S. License No. 2105.*

FDA Label Image

Principal Display Panel (60 mg/mL Syringe Carton)

OSVYRTI 60 mg/mL injection prefilled syringe label showing denosumab-desu as the active ingredient. The single-dose syringe is for subcutaneous use only and contains a sterile solution without preservatives. The label includes storage instructions to refrigerate between 2°C to 8°C, manufacturer details for Accord BioPharma Inc., and highlights that the syringe should be discarded if unused.*

FDA Label Image

Principal Display Panel (60 mg/mL Syringe Carton)

OSVYRTI 60 mg/mL (denosumab-desu) injection packaging label for subcutaneous use by Accord BioPharma Inc. The label includes dosage form information, manufacturer details, NDC 69448-021-63, storage instructions to refrigerate at 2° to 8°C, and directions for use with a single-dose prefilled syringe. The label also notes that the product is for prescription use only and includes a barcode.*

FDA Label Image

Logo1 (Denosumab Logo 1)

FDA Label Image

Logo (Denosumab Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.